Gene PreDiT
Cantanhede
About Gene PreDiT
At Gene PreDiT they believe that every disease and its treatment should be as personalized as possible, and that each patient should have the best treatment according to its condition.It is known that not only each disease has multiple causes, but also that different individuals have different symptomatology and respond differently to the same treatment. It is estimated that only 40% of currently available medications have significant beneficial effects. Therefore it is essential to identify new biomarkers that allow the stratification of patients, in order to develop more effective, customized therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Seed
- Last round: Seed (Dec 2007)
- Website: genepredit.com.pt
- Phone: +351231410893
Industries & Categories
Genetics
Canonical: https://fsome.com/organization/gene-predit-3674952 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.